CLDX - Celldex Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue12,7436,7865,480
Cost of Revenue---
Gross Profit12,7436,7865,480
Operating Expenses
Research Development96,171102,726100,171
Selling General and Administrative24,20335,97933,837
Non Recurring13,00013,00013,000
Total Operating Expenses134,270--
Operating Income or Loss-121,527-132,916-129,541
Income from Continuing Operations
Total Other Income/Expenses Net4,2144,3862,344
Earnings Before Interest and Taxes-117,313-128,530-127,197
Interest Expense---
Income Before Tax-117,313-128,530-127,197
Income Tax Expense-24,282--
Minority Interest---
Net Income From Continuing Ops-93,031-128,530-127,197
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-93,031-128,530-127,197
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-93,031-128,530-127,197